The revival of colistin: an old antibiotic for the 21st century

Pathologie-biologie
R NasnasP Hallak

Abstract

Multidrug resistant Gram-negative rods are emerging as major pathogens and are the cause of difficulty to treat infections. In certain situations colistin is the only active drug. A retrospective review of the patient's charts admitted at Hôtel-Dieu de France hospital, Beirut, between October 2002 and February 2004 and treated with intravenous colistin. Fifteen patients were identified; they were suffering from urinary tract infections, cellulitis, osteomyelitis, mediastinitis and intra-abdominal abscess. The microorganisms were resistant to all available antibiotics except colistin. Three strains were also susceptible to aminoglycosides. Pseudomonas aeruginosa was the most frequently isolated pathogen. Colistin was used in monotherapy in 12 patients and combined with amikacin in three patients. At the end of therapy, a 93% rate of favorable clinical outcome was observed. Renal toxicity was encountered among 12 patients. It was severe in only two cases in which creatinine clearance decline surpassed 50% of the baseline value. No neurological toxicity was observed. Colistin has an important role to play when used for the treatment of infections with multiresistant Gram-negative bacteria. Nephrotoxicity seems much lower than expe...Continue Reading

References

Nov 28, 1970·British Medical Journal·D J Price, D I Graham
Mar 17, 1969·JAMA : the Journal of the American Medical Association·K J RyanG E Striker
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H Nikaido
Oct 8, 1998·The European Respiratory Journal·M J LedsonM J Walshaw
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A S LevinS F Costa
Aug 5, 2000·Respiratory Medicine·J M LittlewoodF Duncan-Skingle
Nov 14, 2001·Current Opinion in Pulmonary Medicine·P Beringer
Sep 14, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Andreas Stein, Didier Raoult
Apr 26, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Garnacho-MonteroJ Madrazo-Osuna
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·John P OuderkirkJay Ward Kislak
Nov 14, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter K LindenDavid Paterson
Dec 18, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A KarabinisH Malamou-Lada
May 25, 2004·Infection and Immunity·Jyoti Mathur, Matthew K Waldor
Jul 29, 2004·The Annals of Pharmacotherapy·Rupali Jain, Larry H Danziger
Nov 4, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D M Livermore
Dec 29, 2004·International Journal of Antimicrobial Agents·Jian LiKingsley Coulthard
Feb 1, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A S MichalopoulosM E Falagas

❮ Previous
Next ❯

Citations

Feb 2, 2013·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Chongshan DaiJian Li
Oct 3, 2015·PLoS Genetics·Alexandro Rodríguez-RojasJens Rolff
Sep 8, 2010·Expert Review of Anti-infective Therapy·Argyris S Michalopoulos, Dimitra C Karatza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Krista WahbyPranatharthi Chandrasekar
Antimicrobial Agents and Chemotherapy
Jumana M YousefJian Li
© 2021 Meta ULC. All rights reserved